EMAP-II, Endothelial-Monocyte Activating Polypeptide II, human

£114.00 exc. VAT

5ug

SKU: RC214-22.SIZE.5ug Category:

EMAP-II, Endothelial-Monocyte Activating Polypeptide II, human: EMAP-II is a tumor derived cytokine that exerts a wide range of activities on endothelial cells, monocytes and neutrophils. EMAP-II inhibits endothelial cell proliferation, vasculogenesis, neovessel formation, and can induce apoptosis. It is also chemotactic towards neutrophils and monocytes and induces myeloperoxidase activity from neutrophils. Of clinical importance, EMAP-II inhibits angiogenesis of vascular beds and suppresses the growth of primary and secondary tumors without affecting normal tissues. Mature EMAP-II is an 18.3 kDa protein, which is synthesized as the C-terminal portion of a biologically inactive precursor protein containing a propeptide of 146 amino acid residues. UnitProt ID: Q12904

CAS
Grade
HS Code

2937.19.0000

Manufacturer

Bio Basic

Pack Size

5ug

Shipping Conditions

ICE

Sterile

yes

Storage Conditions

(-15 to -20)C

UNSPSC Category

Other Cytokines and Chemokines

UNSPSC Code

41116127

DG
Hazard Class
Hazard UN
Shopping Basket
Scroll to Top